108 related articles for article (PubMed ID: 22522123)
1. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells.
Chou HC; Lu YC; Cheng CS; Chen YW; Lyu PC; Lin CW; Timms JF; Chan HL
J Proteomics; 2012 Jun; 75(11):3158-76. PubMed ID: 22522123
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of rhein-induced cyt: ER stress mediates cell death in breast cancer cells.
Huang HJ; Lin CC; Chou HC; Chen YW; Lin ST; Lin YC; Lin DY; Lyu KW; Chan HL
Mol Biosyst; 2014 Dec; 10(12):3086-100. PubMed ID: 25259860
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of evodiamine-induced cytotoxicity in thyroid cancer cells.
Yu HI; Chou HC; Su YC; Lin LH; Lu CH; Chuang HH; Tsai YT; Liao EC; Wei YS; Yang YT; Lee YR; Chan HL
J Pharm Biomed Anal; 2018 Oct; 160():344-350. PubMed ID: 30114613
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells.
Chou HC; Lu CH; Su YC; Lin LH; Yu HI; Chuang HH; Tsai YT; Liao EC; Wei YS; Yang YT; Chien YA; Yu XR; Lee YR; Chan HL
Life Sci; 2018 Aug; 207():184-204. PubMed ID: 29883720
[TBL] [Abstract][Full Text] [Related]
5. Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes.
Lin ST; Chou HC; Chen YW; Chan HL
Mol Biosyst; 2013 Mar; 9(3):447-56. PubMed ID: 23340498
[TBL] [Abstract][Full Text] [Related]
6. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
7. Redox-proteomic analysis of doxorubicin resistance-induced altered thiol activity in uterine carcinoma.
Lin ST; Lo YW; Chang SJ; Wang WC; Chang MD; Lyu PC; Chen YW; Chou HC; Chan HL
J Pharm Biomed Anal; 2013 May; 78-79():1-8. PubMed ID: 23425445
[TBL] [Abstract][Full Text] [Related]
8. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
Kim JB; Yu JH; Ko E; Lee KW; Song AK; Park SY; Shin I; Han W; Noh DY
Phytomedicine; 2010 May; 17(6):436-40. PubMed ID: 19800775
[TBL] [Abstract][Full Text] [Related]
9. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway.
Patil JB; Kim J; Jayaprakasha GK
Eur J Pharmacol; 2010 Oct; 645(1-3):70-8. PubMed ID: 20691179
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
Leong S; McKay MJ; Christopherson RI; Baxter RC
J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
[TBL] [Abstract][Full Text] [Related]
11. Proteomic and redox-proteomic study on the role of glutathione reductase in human lung cancer cells.
Fan CY; Chou HC; Lo YW; Wen YF; Tsai YC; Huang H; Chan HL
Electrophoresis; 2013 Dec; 34(24):3305-14. PubMed ID: 24115172
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of changes in the protein composition of MCF-7 human breast cancer cells induced by all-trans retinoic acid, 9-cis retinoic acid, and their combination.
Flodrova D; Benkovska D; Macejova D; Bialesova L; Hunakova L; Brtko J; Bobalova J
Toxicol Lett; 2015 Jan; 232(1):226-32. PubMed ID: 25455455
[TBL] [Abstract][Full Text] [Related]
13. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells.
Fang HY; Chen SB; Guo DJ; Pan SY; Yu ZL
Phytomedicine; 2011 Jun; 18(8-9):697-703. PubMed ID: 21239154
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis.
Wu CL; Chou HC; Cheng CS; Li JM; Lin ST; Chen YW; Chan HL
J Proteomics; 2012 Apr; 75(7):1991-2014. PubMed ID: 22270008
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
[TBL] [Abstract][Full Text] [Related]
16. Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation.
Kuo HP; Chuang TC; Tsai SC; Tseng HH; Hsu SC; Chen YC; Kuo CL; Kuo YH; Liu JY; Kao MC
J Agric Food Chem; 2012 Sep; 60(38):9649-58. PubMed ID: 22950834
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular target proteins in berberine-treated cervix adenocarcinoma HeLa cells by proteomic and bioinformatic analyses.
Lu B; Zhao J; Xu L; Xu Y; Wang X; Peng J
Phytother Res; 2012 May; 26(5):646-56. PubMed ID: 22517511
[TBL] [Abstract][Full Text] [Related]
18. Identification of stage-specific breast markers using quantitative proteomics.
Shaheed SU; Rustogi N; Scally A; Wilson J; Thygesen H; Loizidou MA; Hadjisavvas A; Hanby A; Speirs V; Loadman P; Linforth R; Kyriacou K; Sutton CW
J Proteome Res; 2013 Dec; 12(12):5696-708. PubMed ID: 24106833
[TBL] [Abstract][Full Text] [Related]
19. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.
Kim S; Han J; Lee SK; Choi MY; Kim J; Lee J; Jung SP; Kim JS; Kim JH; Choe JH; Lee JE; Nam SJ
J Surg Res; 2012 Jul; 176(1):e21-9. PubMed ID: 22381172
[TBL] [Abstract][Full Text] [Related]
20. Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.
Lee YR; Chen YW; Tsai MC; Chou HC; Chan HL
Mol Biosyst; 2012 Oct; 8(12):3314-24. PubMed ID: 23090237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
